Hans-Jurgen Magert

Title: Hans-Jurgen Magert: Innovator in Chemokine Research

Introduction

Hans-Jurgen Magert is a notable inventor based in Hanover, Germany. He has made significant contributions to the field of immunology through his research on chemokines. His work has implications for understanding immune reactions and potential antiviral therapies.

Latest Patents

Hans-Jurgen Magert holds a patent for "Tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3." This patent describes the cloning and molecular characterization of a human tandem gene that contains closely linked coding regions for two new CC type chemokines. These chemokines are important mediators of immune responses and have garnered attention for their antiviral activity against HIV. The patent details the transcription of the tandem gene, leading to a bicistronic mature transcript that includes open reading frames for the factor HCC-1 and the newly designated CC-2. Additionally, alternative splicing of the primary transcript results in another chemokine, CC-3. The patent identifies two functional promoter regions within the tandem gene, providing insights into the structure and expression of the new human CC-2/HCC-1 tandem gene.

Career Highlights

Throughout his career, Hans-Jurgen Magert has worked in various research environments, contributing to advancements in the understanding of chemokines. His innovative research has positioned him as a key figure in the field of immunology.

Collaborations

Hans-Jurgen Magert has collaborated with notable colleagues such as Wolf-Georg Forssmann and Andreas Pardigol. These collaborations have further enriched his research and contributed to the scientific community's understanding of chemokines.

Conclusion

Hans-Jurgen Magert's work in chemokine research exemplifies the importance of innovation in the field of immunology. His patent on tandem cDNAs encoding chemokines highlights his contributions to understanding immune responses and potential antiviral therapies.